Indefinite Delivery Contract 75D30122D12997
Award Date
12/31/21
Last Date to Order
2/28/23
Federal Agency
CDC Pittsburgh
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award to Glaxosmithkline, LLC is for the supply of pediatric influenza vaccines to the Centers for Disease Control and Prevention (CDC) for distribution to immunization programs under the Section 317(j) Public Health Service Act and Vaccines for Children program. The single-award contract has a ceiling value of $161,025,000 and a period of performance from December 31, 2020 to February 28, 2022. The contract was issued in response to a CDC solicitation for a minimum...
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to provide pediatric flu vaccines for the 2020-2021 season. The contract has a potential value of $140.25 million and was awarded to Glaxosmithkline, LLC on January 7, 2020, with an ordering period through February 28, 2021. The original solicitation sought proposals to supply between 60-80 million doses of pediatric flu vaccines for nationwide delivery....
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the pharmaceutical company Glaxosmithkline, LLC to provide pediatric influenza vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $182,592,000 and a period of performance through February 28, 2025. Glaxosmithkline, a foreign-owned for-profit organization, has extensive experience as a prime contractor providing a range of pharmaceutical products and services to...
The Centers for Disease Control and Prevention awarded a single-award indefinite delivery contract to Glaxosmithkline, LLC to procure adult influenza vaccines. The contract has a potential value of $13 million and a period of performance from December 2020 through February 2022. The original solicitation sought proposals for the purchase of influenza vaccines for individuals aged 19 years and older to support immunization programs under Section 317(j) of the Public Health Service Act. Offerors...
The Centers for Disease Control and Prevention awarded a single award indefinite delivery contract to Seqirus USA Inc. with a potential value of $180,705,000. The contract aims to procure pediatric influenza vaccines for children ages 0 through 18 years old to support immunization programs under Section 317(j) of the Public Health Service Act and the Vaccines for Children program. Task orders will be issued against the contract to purchase required vaccines each flu season through February 28,...
The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides adult flu vaccines for the 2023-2024 period. Glaxosmithkline, LLC was awarded a multiple award contract with a potential value of $13.9 million to deliver flu vaccines through February 2028 under associated task orders or price lists. The solicitation aimed to procure adult flu vaccines to support the Centers for Disease Control and Prevention's...
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...
The Centers for Disease Control and Prevention (CDC) has awarded an Indefinite Delivery Contract (IDC) to Seqirus USA Inc., through its Seqirus USA, Inc. division, for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $208,520,000 and a performance period through February 28, 2023. Under this IDC, Seqirus will provide between 100 doses to 50 million doses of pediatric influenza vaccines, in various presentations and National Drug Codes, to support...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The single-award contract has a ceiling value of $11,968,367.50 and a period of performance from March 15, 2010 to February 28, 2011. The contract aims to procure influenza vaccine services for the CDC's Vaccine for Children (VFC) program in 2010. The VFC program provides vaccines at no cost to...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under the Vaccines for Children 2021 program to support pediatric immunization efforts. The contracts hold a potential value of $1.039 billion and were awarded to Glaxosmithkline, LLC for the period of April 1, 2021 through March 31, 2022. The contracts will provide 20 standard pediatric vaccines to the CDC's Immunization Awardees for distribution through the Vaccines for Children program and Section...